Immune Evasion and Viral Carcinogenesis

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".

Deadline for manuscript submissions: 31 March 2026 | Viewed by 61

Special Issue Editors


E-Mail Website
Guest Editor
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
Interests: viral oncogenesis; epigenomics; oncogenic herpesviruses

E-Mail Website
Guest Editor
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
Interests: virology; viral oncogenesis; human herpesviruses; hematology; antiviral therapy; hemato-oncology; cellular therapy; hematopoietic cell transplant; acute graft-versus-host disease (aGVHD)

Special Issue Information

Dear Colleagues,

Immune surveillance has emerged as a key determinant of tumorigenesis, with immune cells, the tumor microenvironment and tumor immune evasion being increasingly linked to treatment efficacy and clinical outcomes. This is especially true for settings that involve oncogenic viruses. Here, the immune system plays a dual role in fighting viral pathogens and the cancers that they induce. Oncogenic viruses co-opt cellular mechanisms to suppress or alter immune responses in their favor, thereby leading to persistent infection and cellular transformation.

This Special Issue explores the interconnection of the immune system and oncogenic viruses, with a focus on immune evasion. We would like to invite you to contribute original research, as well as perspective and review articles, that focus on viral oncogenesis and immune evasion in cancer settings where viruses are important; this includes the tumor-promoting function of viruses such as the human immunodeficiency virus (HIV). The scope of this Special Issue ranges from basic to translational and clinical virology research. Research may focus on all aspects of immunology and virology related to the study of viral immune evasion, including prevention, vaccines, clinical outcomes, biomarkers, therapeutic interventions and in vitro/in vivo models. We also welcome articles that address the development and evaluation of novel technologies and assays aimed at understanding immune evasion in viral oncogenesis. Studies that address the involvement of new viral pathogens in the context of immune evasion are also within the scope of this Special Issue.

It is our hope that this Special Issue will disseminate recent research from the field in order to highlight this relevant aspect of virology.

Dr. Christoph Weigel
Dr. Tuan L. Phan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • viral oncogenesis
  • viral carcinogenesis
  • immune evasion
  • immune surveillance
  • oncogenic viruses
  • immunosuppression
  • host-pathogen interactions

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop